Shareable Research Card

ZENA - ZenaTech, Inc. Common Stock, Value, Issued

This metric view shows ZENA - ZenaTech, Inc. common stock, value, issued history from SEC company facts.

Use it to verify the latest reported value, compare nearby periods, and jump to a cross-company ranking when a curated insight exists.

Context
Latest reported period: Q4 2025
Latest reported value
CA$14,406,266

Based on company facts extracted from SEC 10-Q/10-K XBRL filings where available. Values may differ by reporting period and company taxonomy.

Return Loop

Why revisit this metric view

This metric history becomes more useful after the next quarterly or annual filing because the latest reported value, period, and company comparison context can all change.

Latest source-backed update
Latest period end 31 Dec 2025
Why come back
Return after the next filing to verify whether this metric changed and how it compares with the ranking page.
  • Current latest reported period: Q4 2025.
  • Latest reported value on this page: CA$14,406,266.
  • Save this filer if you want to compare the next reported value with this history.

Metric freshness comes from the latest SEC company fact available for this taxonomy tag and the paired company facts page.

Latest update

Latest update for Common Stock, Value, Issued

New fact period available

Latest reported common stock, value, issued: CA$14,406,266. Open the source-backed page to compare this metric with the newest filing-backed context.

Update date

31 Dec 2025

Page type

Metric history

Latest period

Q4 2025

SEC-backed company facts were refreshed from filings filed on 04 May 2026.

Benchmark Context

How Common Stock, Value, Issued compares with peers

ZenaTech, Inc. sits in the bottom quarter of the current common stock, value, issued sample.

Compared with

Compared with 25 companies reporting common stock, value, issued in CAD. This keeps the comparison on the same metric and unit family.

Why this is notable

This is about 0.1x the current sample midpoint. Common Stock, Value, Issued is up about 91% versus the comparable prior period.

  • Visible rows currently span reported period ends from 30 Jun 2012 to 31 Mar 2026.
  • Nearby companies in this sample: BetterLife Pharma Inc. and SRx Health Solutions, Inc..
  • Current sample position: rank #21 of 25 comparable companies.
  • Peer rows use the latest valid value per company for this exact metric and compatible units.

Peer comparisons use the same metric and compatible units only. Latest reported periods may differ across companies, so open each company page before drawing conclusions.

Save this filer page

Create a free account to keep this page in your watchlists. After verification, we will save it automatically and open your saved research list.

Financial Metric Page

ZenaTech, Inc.: Common Stock, Value, Issued

Latest period: Q4 2025. Period end: 31 Dec 2025. Units: CAD. Frequency: quarterly.

Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.

What This Metric Tells You

  • Shows the reported level of common stock, value, issued over 31 Dec 2023 - 31 Dec 2025.
  • Includes year-over-year change points to highlight acceleration or slowdown.
  • Built from 3 SEC fact rows for this metric and issuer.

How To Read This Chart

  • Start with the latest point, then compare it with the prior periods to see direction.
  • Use quarterly sequence to compare like-for-like periods.
  • Use YoY change bars to separate growth from contraction across matching periods.

Compare This Metric Across Companies

Compare latest available Common Stock, Value, Issued levels across SEC-reporting companies, then open each company metric page for SEC-backed verification. Reporting periods may differ by company.

ZenaTech, Inc. appears at rank #21 in the latest comparison sample.

Rank Company Latest value Reported period Next step
1 ENBRIDGE INC (enb) CA$71,943,000,000 Instant - 31 Mar 2026 Open ENBRIDGE INC Common Stock, Value, Issued
2 CANADIAN PACIFIC KANSAS CITY LTD/CN (cp) CA$24,623,000,000 Instant - 31 Mar 2026 Open CANADIAN PACIFIC KANSAS CITY LTD/CN Common Stock, Value, Issued
3 TRANSCANADA PIPELINES LTD (tcpa) CA$21,761,000,000 Instant - 31 Dec 2017 Open TRANSCANADA PIPELINES LTD Common Stock, Value, Issued
4 Fortis Inc. (fts) CA$16,112,000,000 Instant - 31 Dec 2025 Open Fortis Inc. Common Stock, Value, Issued
5 EMERA INC (ema) CA$9,387,000,000 Instant - 31 Dec 2025 Open EMERA INC Common Stock, Value, Issued
6 Canopy Growth Corp (cgc) CA$9,169,947,000 Instant - 31 Dec 2025 Open Canopy Growth Corp Common Stock, Value, Issued

Metric Details

Metric
Common Stock, Value, Issued (CommonStockValue)
Taxonomy
us-gaap
Units tracked
CAD
Frequency coverage
quarterly
History range
31 Dec 2023 - 31 Dec 2025
Facts on this page
3
Description
Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.
Metric-level SEC endpoint
Open SEC company concept

Chart Context

Compare periods with the same frequency first, then use YoY and TTM series to confirm whether changes are structural or one-off.

Common Stock, Value, Issued, Quarterly (CAD)
Common Stock, Value, Issued, YoY Quarterly Change (%)

ZenaTech, Inc. Quarterly Common Stock, Value, Issued (CAD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 CA$14,406,266 +CA$6,875,929 +91% 31 Dec 2025 20-F/A 04 May 2026 2025 FY
Q4 2024 CA$7,530,337 +CA$2,477,382 +49% 31 Dec 2024 20-F/A 04 May 2026 2025 FY
Q4 2023 CA$5,052,955 31 Dec 2023 20-F/A 27 Feb 2026 2024 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .